Drug Trial Radar · NCT01436175
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Last checked: Nov 19, 2026Latest source record: Jun 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,570
Actual
Start
Feb 27, 2012
Primary completion
Mar 27, 2014
Study completion Mar 27, 2014
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Sep 19, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is an optional continuation of previous short-term adult major depressive disorder (MDD) augmentation studies. Patients may only take part in this long-term, open-label research study if they completed a previous double-blind MDD augmentation study using SPD489.
Conditions
- Major Depressive Disorder
Interventions
SPD489 (Lisdexamfetamine dimesylate) + AntidepressantDrug
SPD489 20mg, 30mg, 50mg, or 70mg + Antidepressant (either escitalopram oxalate, sertraline hydrochloride, venlafaxine hydrochloride extended release or duloxetine hydrochloride) oral, once daily for 52 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: Week 5 up to Week 52/Early Termination(ET)
- Change From Baseline in Systolic Blood Pressure at Week 52Time frame: Baseline, Week 52/ET
- Change From Baseline in Diastolic Blood Pressure at Week 52Time frame: Baseline, Week 52/ET
- Change From Baseline in Pulse Rate at Week 52Time frame: Baseline, Week 52/ET
Locations
212 sites in 14 countries. Site status is shown where the registry gives one.
Birmingham Research Group
Birmingham, Alabama
ResearchOne, Inc.
Scottsdale, Arizona
Arkansas Psychiatric Clinical Research Trials, P.A.
Little Rock, Arkansas
South Coast Clinical Trials, Inc.
Anaheim, California
American Neuropsychiatric Research, Inc.
Carson, California
Catalina Research Institute, LLC
Chino, California
Shanti Clinical Trials
Colton, California
ATP Clinical Research
Costa Mesa, California
Clinical Innovation, Inc.
Costa Mesa, California
Diligent Clinical Trials
Downey, California
Synergy Clinical Research Center of Escondido
Escondido, California
Collaborative Neuroscience Network, Inc.
Garden Grove, California
UC, Irvine Child Development Center
Irvine, California
Irvine Center For Clinical Research
Irvine, California
Omega Clinical Trials, LLC
La Habra, California
Semel Institute for Neuroscience & Human Behavior at UCLA
Los Angeles, California
Pacific Research Partners
Oakland, California
North County Clinical Research
Oceanside, California
Pasadena Research Institute, LLC
Pasadena, California
Anderson Clinical Research
Redlands, California
BreakThrough Clinical Trials, LLC
San Bernardino, California
Affiliated Research Institute
San Diego, California
PCSD - Feighner Research
San Diego, California
Clinical Innovations, Inc.
San Diego, California
Sharp Mesa Vista Hospital
San Diego, California
Artemis Institute for Clinical Research
San Diego, California
Neuropsychiatric Center of Orange County
Santa Ana, California
Caliifornia Neuroscience Research Medical Group
Sherman Oaks, California
MCB Clinical Research Centers
Colorado Springs, Colorado
Western Affiliated Research Institute
Denver, Colorado
Connecticut Clinical Research
Cromwell, Connecticut
Geriatric and Adult Psychiatry, LLC
Hamden, Connecticut
Institute of Living - Hartford Hospital
Hartford, Connecticut
The Hospital of Central Connecticut
New Britain, Connecticut
Florida Clinical Research Center, LLC
Bradenton, Florida
CNS Clinical Research Group
Coral Springs, Florida
Gulfcoast Clinical Research Center
Fort Myers, Florida
Emerald Coast Mood & Memory, PA
Fort Walton Beach, Florida
Sarkis Clinical Trials
Gainesville, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Showing 40 of 212 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.